1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Dental Biomaterials - Pipeline Review, 2015

Dental Biomaterials - Pipeline Review, 2015

  • October 2015
  • -
  • Global Data
  • -
  • 80 pages

Dental Biomaterials - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Dental Biomaterials - Pipeline Review, 2015" provides an overview of Dental Biomaterials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Biomaterials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dental Biomaterials under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dental Biomaterials and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dental Biomaterials under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Dental Biomaterials - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2


2 Introduction 7
2.1 Dental Biomaterials Overview 7
3 Products under Development 8
3.1 Dental Biomaterials - Pipeline Products by Stage of Development 8
3.2 Dental Biomaterials - Pipeline Products by Segment 9
3.3 Dental Biomaterials - Pipeline Products by Territory 10
3.4 Dental Biomaterials - Pipeline Products by Regulatory Path 11
3.5 Dental Biomaterials - Pipeline Products by Estimated Approval Date 12
3.6 Dental Biomaterials - Ongoing Clinical Trials 13
4 Dental Biomaterials - Pipeline Products under Development by Companies 14
4.1 Dental Biomaterials Companies - Pipeline Products by Stage of Development 14
4.2 Dental Biomaterials - Pipeline Products by Stage of Development 16
5 Dental Biomaterials Companies and Product Overview 18
5.1 3-D Matrix, Ltd. Company Overview 18
5.1.1 3-D Matrix, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 18
5.2 Advanced Medical Solutions Group plc Company Overview 20
5.2.1 Advanced Medical Solutions Group plc Pipeline Products and Ongoing Clinical Trials Overview 20
5.3 botiss dental GmbH Company Overview 28
5.3.1 botiss dental GmbH Pipeline Products and Ongoing Clinical Trials Overview 28
5.4 CollPlant Ltd. Company Overview 34
5.4.1 CollPlant Ltd. Pipeline Products and Ongoing Clinical Trials Overview 34
5.5 CoreBone Ltd. Company Overview 35
5.5.1 CoreBone Ltd. Pipeline Products and Ongoing Clinical Trials Overview 35
5.6 Harvard University Company Overview 36
5.6.1 Harvard University Pipeline Products and Ongoing Clinical Trials Overview 36
5.7 Histocell S.L. Company Overview 37
5.7.1 Histocell S.L. Pipeline Products and Ongoing Clinical Trials Overview 37
5.8 Ironwood Material Science Inc Company Overview 38
5.8.1 Ironwood Material Science Inc Pipeline Products and Ongoing Clinical Trials Overview 38
5.9 Lacerta Technologies GmbH Company Overview 39
5.9.1 Lacerta Technologies GmbH Pipeline Products and Ongoing Clinical Trials Overview 39
5.10 Maxigen Biotech Inc. Company Overview 40
5.10.1 Maxigen Biotech Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
5.11 Medisse BV Company Overview 43
5.11.1 Medisse BV Pipeline Products and Ongoing Clinical Trials Overview 43
5.12 Medtronic plc Company Overview 44
5.12.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 44
5.13 Meta Biomed Co., Ltd. Company Overview 47
5.13.1 Meta Biomed Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 47
5.14 NDSU Research Foundation Company Overview 51
5.14.1 NDSU Research Foundation Pipeline Products and Ongoing Clinical Trials Overview 51
5.15 Noraker Company Overview 52
5.15.1 Noraker Pipeline Products and Ongoing Clinical Trials Overview 52
5.16 NovaBone Products, LLC. Company Overview 54
5.16.1 NovaBone Products, LLC. Pipeline Products and Ongoing Clinical Trials Overview 54
5.17 Novatissue SAS Company Overview 55
5.17.1 Novatissue SAS Pipeline Products and Ongoing Clinical Trials Overview 55
5.18 REGENECURE, Ltd. Company Overview 56
5.18.1 REGENECURE, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 56
5.19 Straumann Holding AG Company Overview 59
5.19.1 Straumann Holding AG Pipeline Products and Ongoing Clinical Trials Overview 59
5.20 SurgaColl Technologies Ltd Company Overview 62
5.20.1 SurgaColl Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview 62
5.21 The University of Queensland Company Overview 63
5.21.1 The University of Queensland Pipeline Products and Ongoing Clinical Trials Overview 63
5.22 Tigran Technologies AB Company Overview 64
5.22.1 Tigran Technologies AB Pipeline Products and Ongoing Clinical Trials Overview 64
5.23 Universitat Politecnica de Catalunya Company Overview 65
5.23.1 Universitat Politecnica de Catalunya Pipeline Products and Ongoing Clinical Trials Overview 65
5.24 University of Strasbourg Company Overview 67
5.24.1 University of Strasbourg Pipeline Products and Ongoing Clinical Trials Overview 67
6 Dental Biomaterials- Recent Developments 68
7 Appendix 77
7.1 Methodology 77
7.2 About GlobalData 79
7.3 Contact Us 80
7.4 Disclaimer 80

1.1 List of Tables
Table 1: Dental Biomaterials - Pipeline Products by Stage of Development 8
Table 2: Dental Biomaterials - Pipeline Products by Segment 9
Table 3: Dental Biomaterials - Pipeline Products by Territory 10
Table 4: Dental Biomaterials - Pipeline Products by Regulatory Path 11
Table 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date 12
Table 6: Dental Biomaterials - Ongoing Clinical Trials 13
Table 7: Dental Biomaterials Companies - Pipeline Products by Stage of Development 14
Table 8: Dental Biomaterials - Pipeline Products by Stage of Development 16
Table 9: 3-D Matrix, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 18
Table 10: TDM-711 - Product Status 19
Table 11: TDM-711 - Product Description 19
Table 12: Advanced Medical Solutions Group plc Pipeline Products and Ongoing Clinical Trials Overview 20
Table 13: PARASORB Cone - Product Status 21
Table 14: PARASORB Cone - Product Description 21
Table 15: PARASORB Cone Genta - Product Status 22
Table 16: PARASORB Cone Genta - Product Description 22
Table 17: PARASORB Fleece - Product Status 23
Table 18: PARASORB Fleece - Product Description 23
Table 19: PARASORB Fleece Genta HD - Product Status 24
Table 20: PARASORB Fleece Genta HD - Product Description 24
Table 21: PARASORB Fleece HD - Product Status 25
Table 22: PARASORB Fleece HD - Product Description 25
Table 23: PARASORB RESODONT - Product Status 26
Table 24: PARASORB RESODONT - Product Description 26
Table 25: PARASORB Sombrero - Product Status 27
Table 26: PARASORB Sombrero - Product Description 27
Table 27: botiss dental GmbH Pipeline Products and Ongoing Clinical Trials Overview 28
Table 28: cerabone - Product Status 29
Table 29: cerabone - Product Description 29
Table 30: maxresorb - Product Status 30
Table 31: maxresorb - Product Description 30
Table 32: maxresorb Inject - Product Status 31
Table 33: maxresorb Inject - Product Description 31
Table 34: mucoderm - Product Status 32
Table 35: mucoderm - Product Description 32
Table 36: perossal - Product Status 33
Table 37: perossal - Product Description 33
Table 38: CollPlant Ltd. Pipeline Products and Ongoing Clinical Trials Overview 34
Table 39: VergenixAR - Product Status 34
Table 40: VergenixAR - Product Description 34
Table 41: CoreBone Ltd. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 42: Dental Bone Graft - Product Status 35
Table 43: Dental Bone Graft - Product Description 35
Table 44: Harvard University Pipeline Products and Ongoing Clinical Trials Overview 36
Table 45: Artificial Teeth - Product Status 36
Table 46: Artificial Teeth - Product Description 36
Table 47: Histocell S.L. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 48: Neofibrin - Product Status 37
Table 49: Neofibrin - Product Description 37
Table 50: Ironwood Material Science Inc Pipeline Products and Ongoing Clinical Trials Overview 38
Table 51: GEMOSIL - Dental Implant - Product Status 38
Table 52: GEMOSIL - Dental Implant - Product Description 38
Table 53: Lacerta Technologies GmbH Pipeline Products and Ongoing Clinical Trials Overview 39
Table 54: Albumin Bone Graft - Product Status 39
Table 55: Albumin Bone Graft - Product Description 39
Table 56: Maxigen Biotech Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 57: MaxiBone - Product Status 41
Table 58: MaxiBone - Product Description 41
Table 59: MaxiGuide - Product Status 42
Table 60: MaxiGuide - Product Description 42
Table 61: Medisse BV Pipeline Products and Ongoing Clinical Trials Overview 43
Table 62: Dental Membrane - Product Status 43
Table 63: Dental Membrane - Product Description 43
Table 64: Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 44
Table 65: MD05-P Bone Graft Substitute Material - Product Status 45
Table 66: MD05-P Bone Graft Substitute Material - Product Description 45
Table 67: MD08 Injectable Paste - Product Status 46
Table 68: MD08 Injectable Paste - Product Description 46
Table 69: Meta Biomed Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 70: Biocompatible Sealer - Product Status 48
Table 71: Biocompatible Sealer - Product Description 48
Table 72: Endodontic Sealer - Product Status 49
Table 73: Endodontic Sealer - Product Description 49
Table 74: Root Canal Sealer - Product Status 50
Table 75: Root Canal Sealer - Product Description 50
Table 76: NDSU Research Foundation Pipeline Products and Ongoing Clinical Trials Overview 51
Table 77: Synthetic Mandible - Product Status 51
Table 78: Synthetic Mandible - Product Description 51
Table 79: Noraker Pipeline Products and Ongoing Clinical Trials Overview 52
Table 80: Bone Grafting Device - Dental Surgery - Product Status 52
Table 81: Bone Grafting Device - Dental Surgery - Product Description 52
Table 82: Self-Hardening Injectable Substitute - Dental Surgery - Product Status 53
Table 83: Self-Hardening Injectable Substitute - Dental Surgery - Product Description 53
Table 84: NovaBone Products, LLC. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 85: Bioengineered Resorbable Bone Graft - Dental - Product Status 54
Table 86: Bioengineered Resorbable Bone Graft - Dental - Product Description 54
Table 87: Novatissue SAS Pipeline Products and Ongoing Clinical Trials Overview 55
Table 88: Dental NovaOss - Product Status 55
Table 89: Dental NovaOss - Product Description 55
Table 90: REGENECURE, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 56
Table 91: Regenecure AMCA GBR Dental Membrane Implant - Product Status 56
Table 92: Regenecure AMCA GBR Dental Membrane Implant - Product Description 56
Table 93: REGENECURE, Ltd. - Ongoing Clinical Trials Overview 57
Table 94: Regenecure AMCA GBR Dental Membrane Implant - Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective Controlled Study 58
Table 95: Straumann Holding AG Pipeline Products and Ongoing Clinical Trials Overview 59
Table 96: Enhanced Bone Graft - Product Status 60
Table 97: Enhanced Bone Graft - Product Description 60
Table 98: Soft Tissue Control Implant - Product Status 61
Table 99: Soft Tissue Control Implant - Product Description 61
Table 100: SurgaColl Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview 62
Table 101: DentaColl - Product Status 62
Table 102: DentaColl - Product Description 62
Table 103: The University of Queensland Pipeline Products and Ongoing Clinical Trials Overview 63
Table 104: Dental Material - Product Status 63
Table 105: Dental Material - Product Description 63
Table 106: Tigran Technologies AB Pipeline Products and Ongoing Clinical Trials Overview 64
Table 107: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status 64
Table 108: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description 64
Table 109: Universitat Politecnica de Catalunya Pipeline Products and Ongoing Clinical Trials Overview 65
Table 110: Inorganic Dental Cement - Product Status 66
Table 111: Inorganic Dental Cement - Product Description 66
Table 112: University of Strasbourg Pipeline Products and Ongoing Clinical Trials Overview 67
Table 113: Nanostructured Biomaterial - Product Status 67
Table 114: Nanostructured Biomaterial - Product Description 67
Table 115: Glossary 78

1.2 List of Figures
Figure 1: Dental Biomaterials - Pipeline Products by Stage of Development 8
Figure 2: Dental Biomaterials - Pipeline Products by Segment 9
Figure 3: Dental Biomaterials - Pipeline Products by Territory 10
Figure 4: Dental Biomaterials - Pipeline Products by Regulatory Path 11
Figure 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date 12
Figure 6: Dental Biomaterials - Ongoing Clinical Trials 13

Companies Mentioned
3-D Matrix, Ltd.
Advanced Medical Solutions Group plc
botiss dental GmbH
CollPlant Ltd.
CoreBone Ltd.
Harvard University
Histocell S.L.
Ironwood Material Science Inc
Lacerta Technologies GmbH
Maxigen Biotech Inc.
Medisse BV
Medtronic plc
Meta Biomed Co.,

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.